Fiduciary Alliance LLC Increases Stake in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Fiduciary Alliance LLC grew its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBIFree Report) by 8.4% in the 1st quarter, HoldingsChannel reports. The institutional investor owned 23,033 shares of the exchange traded fund’s stock after acquiring an additional 1,789 shares during the period. Fiduciary Alliance LLC’s holdings in SPDR S&P Biotech ETF were worth $2,162,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently modified their holdings of XBI. Avoro Capital Advisors LLC purchased a new position in shares of SPDR S&P Biotech ETF during the 4th quarter valued at about $396,844,000. Healthcare of Ontario Pension Plan Trust Fund boosted its stake in shares of SPDR S&P Biotech ETF by 35.9% during the 4th quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 2,406,000 shares of the exchange traded fund’s stock worth $214,832,000 after purchasing an additional 635,000 shares during the period. Employees Retirement System of Texas purchased a new stake in SPDR S&P Biotech ETF in the third quarter worth $27,456,000. Blackstone Inc. raised its stake in shares of SPDR S&P Biotech ETF by 674.8% during the fourth quarter. Blackstone Inc. now owns 337,030 shares of the exchange traded fund’s stock valued at $30,093,000 after acquiring an additional 293,530 shares in the last quarter. Finally, abrdn plc purchased a new stake in SPDR S&P Biotech ETF in the fourth quarter worth about $14,436,000.

SPDR S&P Biotech ETF Price Performance

SPDR S&P Biotech ETF stock traded down $0.15 during trading hours on Friday, reaching $92.71. The stock had a trading volume of 7,872,582 shares, compared to its average volume of 10,728,328. The company has a market cap of $7.07 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a 52 week low of $63.80 and a 52 week high of $103.52. The business’s 50 day moving average price is $89.95 and its 200-day moving average price is $90.80.

About SPDR S&P Biotech ETF

(Free Report)

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

Featured Stories

Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBIFree Report).

Institutional Ownership by Quarter for SPDR S&P Biotech ETF (NYSEARCA:XBI)

Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.